A share price of DENTSPLY Sirona Inc [XRAY] is currently trading at $25.29, up 0.52%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The XRAY shares have lost -0.63% over the last week, with a monthly amount drifted -8.50%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
DENTSPLY Sirona Inc [NASDAQ: XRAY] stock has seen the most recent analyst activity on February 26, 2024, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $42. Previously, Needham started tracking the stock with Buy rating on November 16, 2023, and set its price target to $35. On November 10, 2023, upgrade upgraded it’s rating to Outperform. William Blair upgraded its rating to a Mkt Perform. William Blair downgraded its rating to a Underperform. UBS upgraded its rating to Buy for this stock on June 02, 2022, and downed its price target to $47. In a note dated April 20, 2022, William Blair downgraded an Mkt Perform rating on this stock.
DENTSPLY Sirona Inc experienced fluctuations in its stock price throughout the past year between $24.82 and $41.65. Currently, Wall Street analysts expect the stock to reach $46.13 within the next 12 months. DENTSPLY Sirona Inc [NASDAQ: XRAY] shares were valued at $25.29 at the most recent close of the market. An investor can expect a potential return of 82.4% based on the average XRAY price forecast.
Analyzing the XRAY fundamentals
Trailing Twelve Months sales for DENTSPLY Sirona Inc [NASDAQ:XRAY] were 3.94B which represents -2.56% decline. Gross Profit Margin for this corporation currently stands at 0.53% with Operating Profit Margin at -0.02%, Pretax Profit Margin comes in at -0.05%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.03 and Total Capital is -0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.64.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 25.01 points at the first support level, and at 24.73 for the second support level. However, for the 1st resistance point, the stock is sitting at 25.46, and for the 2nd resistance point, it is at 25.63.
Ratios To Look Out For
To put it in perspective, the Current Ratio for DENTSPLY Sirona Inc [NASDAQ:XRAY] is 1.43. Further, the Quick Ratio stands at 0.97, while the Cash Ratio is 0.22. Considering the valuation of this stock, the price to sales ratio is 1.33, the price to book ratio is 1.61.
Transactions by insiders
Recent insider trading involved LUCIER GREGORY T, Director, that happened on May 31 ’24 when 3577.0 shares were purchased. Director, LUCIER GREGORY T completed a deal on Nov 22 ’23 to buy 10000.0 shares. Meanwhile, Executive VP & CFO Coleman Glenn bought 10000.0 shares on Nov 20 ’23.
